CA Stock MarketDetailed Quotes

DRUG Bright Minds Biosciences Inc

Watchlist
  • 60.510
  • -6.250-9.36%
15min DelayMarket Closed Feb 14 15:59 ET
426.23MMarket Cap-302.55P/E (TTM)

Bright Minds Biosciences Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
48.30%-7.02M
43.74%-1.2M
42.33%-1.65M
58.51%-1.51M
Net income from continuing operations
102.95%49.61K
61.99%-2.8M
49.38%-773.44K
115.77%229.9K
72.00%-574.14K
27.88%-1.68M
50.74%-7.37M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
Operating gains losses
-3,953.47%-1.63M
-122.33%-10.13K
-109.17%-14.98K
69.64%-39.61K
-59.39%2.17K
500.01%42.3K
117.52%45.35K
417.62%163.44K
-467.93%-130.47K
-23.72%5.33K
Depreciation and amortization
18.88%21.53K
1.25%73.36K
5.01%19.02K
0.00%18.11K
-0.01%18.11K
0.01%18.11K
1,100.10%72.45K
200.02%18.11K
--18.11K
--18.11K
Asset impairment expenditure
----
--0
----
----
----
----
--0
----
----
----
Remuneration paid in stock
-19.44%176.39K
-27.11%839.77K
-47.51%210.24K
-22.56%183.94K
656.58%226.64K
-54.78%218.95K
31.66%1.15M
1,238.78%400.5K
-19.04%237.54K
-89.70%29.96K
Other non cashItems
117.33%6.46K
-54.71%8.95K
-31.14%2.61K
-72.88%1.24K
-60.14%2.13K
-50.93%2.97K
-32.88%19.75K
74.23%3.79K
--4.58K
--5.33K
Change In working capital
-120.45%-118.56K
104.23%39.81K
136.57%93.39K
52.35%-153.43K
-200.16%-479.99K
168.74%579.85K
-230.05%-941.72K
-130.26%-255.36K
35.77%-322K
-11.94%479.25K
-Change in receivables
-108.43%-16.8K
-111.15%-13.24K
-149.46%-32.99K
862.32%536.01K
-2,061.29%-508.21K
-108.35%-8.06K
360.33%118.8K
173.02%66.7K
-162.80%-70.31K
197.00%25.91K
-Change in prepaid assets
-843.64%-41.32K
-238.17%-188.94K
-238.82%-158.31K
-215.89%-43K
181.02%16.76K
-169.82%-4.38K
3,519.30%136.74K
235.54%114.04K
662.24%37.11K
-136.29%-20.68K
-Change in payables and accrued expense
-110.20%-60.44K
120.21%241.99K
165.28%284.69K
-123.84%-646.44K
-97.58%11.46K
162.58%592.29K
-256.30%-1.2M
-142.79%-436.1K
53.28%-288.8K
-7.76%474.02K
Cash from discontinued investing activities
Operating cash flow
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
48.30%-7.02M
43.74%-1.2M
42.33%-1.65M
58.51%-1.51M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
5,826.92%52.04M
-62.98%810.57K
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
-61.05%878.04K
-57.86%2.19M
-100.43%-21.65K
-279.08%-21.49K
-1,376.13%-21.49K
Net issuance payments of debt
-8.35%-23.79K
-4.20%-89.73K
-10.23%-23.86K
-2.18%-21.96K
-2.17%-21.96K
-2.18%-21.96K
-1,102.35%-86.11K
-187.14%-21.65K
---21.49K
32.84%-21.49K
Net common stock issuance
5,303.22%48.63M
-26.08%900K
--0
--0
--0
-26.08%900K
-69.83%1.22M
--0
--0
--0
Proceeds from stock option exercised by employees
--3.52M
-99.97%302
--302
--0
--0
--0
-44.87%1.09M
--0
--0
--0
Net other financing activities
---83.72K
----
----
----
----
----
96.63%-26.98K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
5,826.92%52.04M
-62.98%810.57K
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
-61.05%878.04K
-57.86%2.19M
-100.43%-21.65K
-279.08%-21.49K
-1,376.13%-21.49K
Net cash flow
Beginning cash position
-15.23%5.72M
-41.97%6.75M
-23.86%6.19M
-38.66%5.93M
-39.69%6.76M
-41.97%6.75M
-41.15%11.63M
-5.90%8.13M
-15.66%9.67M
-25.84%11.21M
Current changes in cash
90,232.60%50.55M
78.50%-1.04M
60.08%-486.73K
113.05%218.2K
46.09%-827.05K
113.67%55.96K
42.38%-4.83M
-141.53%-1.22M
41.33%-1.67M
57.90%-1.53M
Effect of exchange rate changes
3,954.03%1.63M
125.84%11.72K
110.14%16.58K
-69.64%39.61K
59.39%-2.17K
-500.01%-42.3K
-117.52%-45.35K
-417.62%-163.44K
467.93%130.47K
23.72%-5.33K
End cash Position
756.25%57.9M
-15.23%5.72M
-15.23%5.72M
-23.86%6.19M
-38.66%5.93M
-39.69%6.76M
-41.97%6.75M
-41.97%6.75M
-5.90%8.13M
-15.66%9.67M
Free cash from
-81.78%-1.49M
73.66%-1.85M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
48.30%-7.02M
43.74%-1.2M
42.33%-1.65M
58.51%-1.51M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K69.14%-822.09K48.30%-7.02M43.74%-1.2M42.33%-1.65M58.51%-1.51M
Net income from continuing operations 102.95%49.61K61.99%-2.8M49.38%-773.44K115.77%229.9K72.00%-574.14K27.88%-1.68M50.74%-7.37M48.40%-1.53M45.14%-1.46M54.31%-2.05M
Operating gains losses -3,953.47%-1.63M-122.33%-10.13K-109.17%-14.98K69.64%-39.61K-59.39%2.17K500.01%42.3K117.52%45.35K417.62%163.44K-467.93%-130.47K-23.72%5.33K
Depreciation and amortization 18.88%21.53K1.25%73.36K5.01%19.02K0.00%18.11K-0.01%18.11K0.01%18.11K1,100.10%72.45K200.02%18.11K--18.11K--18.11K
Asset impairment expenditure ------0------------------0------------
Remuneration paid in stock -19.44%176.39K-27.11%839.77K-47.51%210.24K-22.56%183.94K656.58%226.64K-54.78%218.95K31.66%1.15M1,238.78%400.5K-19.04%237.54K-89.70%29.96K
Other non cashItems 117.33%6.46K-54.71%8.95K-31.14%2.61K-72.88%1.24K-60.14%2.13K-50.93%2.97K-32.88%19.75K74.23%3.79K--4.58K--5.33K
Change In working capital -120.45%-118.56K104.23%39.81K136.57%93.39K52.35%-153.43K-200.16%-479.99K168.74%579.85K-230.05%-941.72K-130.26%-255.36K35.77%-322K-11.94%479.25K
-Change in receivables -108.43%-16.8K-111.15%-13.24K-149.46%-32.99K862.32%536.01K-2,061.29%-508.21K-108.35%-8.06K360.33%118.8K173.02%66.7K-162.80%-70.31K197.00%25.91K
-Change in prepaid assets -843.64%-41.32K-238.17%-188.94K-238.82%-158.31K-215.89%-43K181.02%16.76K-169.82%-4.38K3,519.30%136.74K235.54%114.04K662.24%37.11K-136.29%-20.68K
-Change in payables and accrued expense -110.20%-60.44K120.21%241.99K165.28%284.69K-123.84%-646.44K-97.58%11.46K162.58%592.29K-256.30%-1.2M-142.79%-436.1K53.28%-288.8K-7.76%474.02K
Cash from discontinued investing activities
Operating cash flow -81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K69.14%-822.09K48.30%-7.02M43.74%-1.2M42.33%-1.65M58.51%-1.51M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 5,826.92%52.04M-62.98%810.57K-8.83%-23.56K-2.18%-21.96K-2.17%-21.96K-61.05%878.04K-57.86%2.19M-100.43%-21.65K-279.08%-21.49K-1,376.13%-21.49K
Net issuance payments of debt -8.35%-23.79K-4.20%-89.73K-10.23%-23.86K-2.18%-21.96K-2.17%-21.96K-2.18%-21.96K-1,102.35%-86.11K-187.14%-21.65K---21.49K32.84%-21.49K
Net common stock issuance 5,303.22%48.63M-26.08%900K--0--0--0-26.08%900K-69.83%1.22M--0--0--0
Proceeds from stock option exercised by employees --3.52M-99.97%302--302--0--0--0-44.87%1.09M--0--0--0
Net other financing activities ---83.72K--------------------96.63%-26.98K--0--0--0
Cash from discontinued financing activities
Financing cash flow 5,826.92%52.04M-62.98%810.57K-8.83%-23.56K-2.18%-21.96K-2.17%-21.96K-61.05%878.04K-57.86%2.19M-100.43%-21.65K-279.08%-21.49K-1,376.13%-21.49K
Net cash flow
Beginning cash position -15.23%5.72M-41.97%6.75M-23.86%6.19M-38.66%5.93M-39.69%6.76M-41.97%6.75M-41.15%11.63M-5.90%8.13M-15.66%9.67M-25.84%11.21M
Current changes in cash 90,232.60%50.55M78.50%-1.04M60.08%-486.73K113.05%218.2K46.09%-827.05K113.67%55.96K42.38%-4.83M-141.53%-1.22M41.33%-1.67M57.90%-1.53M
Effect of exchange rate changes 3,954.03%1.63M125.84%11.72K110.14%16.58K-69.64%39.61K59.39%-2.17K-500.01%-42.3K-117.52%-45.35K-417.62%-163.44K467.93%130.47K23.72%-5.33K
End cash Position 756.25%57.9M-15.23%5.72M-15.23%5.72M-23.86%6.19M-38.66%5.93M-39.69%6.76M-41.97%6.75M-41.97%6.75M-5.90%8.13M-15.66%9.67M
Free cash from -81.78%-1.49M73.66%-1.85M61.32%-463.17K114.55%240.16K46.77%-805.09K69.14%-822.09K48.30%-7.02M43.74%-1.2M42.33%-1.65M58.51%-1.51M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.